---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-23-000119"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T09:17:36.439932+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MariMed Q3 revenue $38.8M (+14% YoY), GAAP net loss of $4.3M vs profit a year ago

## Summary
- Revenue of $38.8M for Q3 2023, up 14% from $33.9M in Q3 2022.
- GAAP net loss of $4.3M, compared to net income of $2.7M in the prior-year quarter.
- Non-GAAP adjusted EBITDA of $6.1M (16% margin) vs $8.6M (25% margin) a year ago.
- Reported 15th consecutive quarter of positive adjusted EBITDA.
- Maryland adult-use sales launched July 1; wholesale business set quarterly records.

## SEC filing metadata
- accession: 0001522767-23-000119
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/0001522767-23-000119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/mrmd-20231108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-23-000119
- JSON: https://secwatch.observer/filing/0001522767-23-000119.json
- Plain text: https://secwatch.observer/filing/0001522767-23-000119.txt

## Key facts
- Earnings Releases
  MARIMED INC. reported three months ended September 30, 2023 results: revenue $ 38.8, net income $ (4.3).
  - Period: three months ended September 30, 2023
  - Revenue: $ 38.8
  - Net income: $ (4.3)
  - Result: reported results
  source text: Three months ended September 30, Nine months ended September 30, 2023 2022 2023 2022 Revenue $ 38.8 $ 33.9 $ 109.7 $ 98.2 GAAP Gross margin 43 % 48 % 44 % 49 % Non-GAAP Gross margin 45 % 48 % 45 % 49 % GAAP Net (loss) income $ (4.3) $ 2.7 $ (5.9) $ 8.9 Non-GAAP Net (loss) income $ (3.1) $ 4.7 $ (2.2) $ 17.0 Non-GAAP Adjusted EBITDA $ 6.1 $ 8.6 $ 19.4 $ 27.9 Non-GAAP Adjusted EBITDA margin 16 % 25 % 18 % 28 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/0001522767-23-000119-index.htm
- Earnings Releases
  MARIMED INC. reported nine months ended September 30, 2023 results: revenue $ 109.7, net income $ (5.9).
  - Period: nine months ended September 30, 2023
  - Revenue: $ 109.7
  - Net income: $ (5.9)
  - Result: reported results
  source text: Three months ended September 30, Nine months ended September 30, 2023 2022 2023 2022 Revenue $ 38.8 $ 33.9 $ 109.7 $ 98.2 GAAP Gross margin 43 % 48 % 44 % 49 % Non-GAAP Gross margin 45 % 48 % 45 % 49 % GAAP Net (loss) income $ (4.3) $ 2.7 $ (5.9) $ 8.9 Non-GAAP Net (loss) income $ (3.1) $ 4.7 $ (2.2) $ 17.0 Non-GAAP Adjusted EBITDA $ 6.1 $ 8.6 $ 19.4 $ 27.9 Non-GAAP Adjusted EBITDA margin 16 % 25 % 18 % 28 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522767/000152276723000119/0001522767-23-000119-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.